TG Therapeutics, Inc. (NASDAQ: TGTX), today announced several updated poster presentations at MSToronto2026, the 10th Joint ACTRIMS-ECTRIMS Meeting. The presentations include seven-year follow up data ...

Washington State University researchers have discovered how to "crank up" a natural defense system in the body to combat ...

Don't fall for "critical alert" pop-ups or notifications in your browser. Learn why these happen and how to put a stop to ...

ROMULUS uses ClickFix lures and PowerShell scripts to deliver malware, including Legion Loader, across infrastructure ...

The FDA-approved, new mRNA flu shot is now available for adults 50 and older. HealthLink explores how it stacks up against ...

Fiji's declaration of a national HIV crisis has set off a torrent of online falsehoods, blaming the Pacific nation's robust ...

GSK's ViiV Healthcare reports Cabenuva's superior viral suppression in HIV, and the company advances key acquisitions and ...

FLINTLOCK Phase 2 clinical trial will evaluate the safety, tolerability, pharmacokinetics, and clinical efficacy of high-dose monoclonal antibody VYD2311 in adults aged 18-65 years with Long COVID or ...

Spread the loveImagine waking up one morning to find your smart toaster refusing to toast, your refrigerator ordering a truckload of kale, and your smart TV inexplicably displaying cryptic messages – ...

Hong Kong Customs today (October 13) detected a suspected smuggling case involving an outgoing lorry at the Hong ...

Over decades of sustained, integrated national viral hepatitis control, Japan has seen substantial reductions in HBV- and HCV ...